Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAlpsoy, Şeref
dc.contributor.authorErselcan, Kubilay
dc.contributor.authorAkyüz, Aydın
dc.contributor.authorÖzkaramanlı Gür, Demet
dc.contributor.authorTopuz, Sahin
dc.contributor.authorTopçu, Birol
dc.contributor.authorGüler, Niyazi
dc.date.accessioned2022-05-11T14:40:10Z
dc.date.available2022-05-11T14:40:10Z
dc.date.issued2020
dc.identifier.issn2148-4902
dc.identifier.urihttps://doi.org/10.14744/nci.2019.07078
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8886
dc.description.abstractOBJECTIVE: Our aim is to determine the triggering factors of paroxysmal atrial fibrillation (PAF) in ischemic heart failure (HF) patients with low ejection fraction (EF). METHODS: Sixty patients were included in this study. Echocardiography and 24-hours Holter monitoring were performed after measurement of serum NT-pro BNP concentration. The patients were classified into two groups concerning the occurrence of PAF on Holter recordings. Biochemical and echocardiographic parameters of patients with and without PAF were compared. RESULTS: PAF was detected in 28 (46%) patients. Patients with PAF demonstrated higher NT-pro BNP levels, mitral and aortic regurgitation velocities, E/A, E/E', pulmonary capillary wedge pressure, pulmonary artery systolic pressure, left atrial volume and volume indices. NT-pro BNP was established as the predictor of PAF (OR=1.23, 95% CI: 1.08-1.42; p=0.001).ROC analysis showed an NT-pro BNP value of 2188 pg/mL as cut-off value with 68% sensitivity and 84% specificity [Area under the ROC curve (AUC)=0.826, CI 95%: 0.724-0.927; p<0.001]. CONCLUSION: The triggering factors for AF are increased intracardiac pressures, left atrial dilatation and increased wall tension. As an indicator of increased wall tension, elevated levels of NT-pro BNP predict the development of PAF.en_US
dc.language.isoengen_US
dc.publisherKare Publen_US
dc.identifier.doi10.14744/nci.2019.07078
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAtrial fibrillationen_US
dc.subjectheart failureen_US
dc.subjectischemicen_US
dc.subjectlow ejection fractionen_US
dc.subject2016 Esc Guidelinesen_US
dc.subjectNatriuretic Peptideen_US
dc.subjectRisk-Factorsen_US
dc.subjectAssociationen_US
dc.subjectCollaborationen_US
dc.subjectManagementen_US
dc.subjectSocietyen_US
dc.titleCan the development of atrial fibrillation in patients with ischemic heart failure with low ejection fraction be predicted?en_US
dc.typearticleen_US
dc.relation.ispartofNorthern Clinics of Istanbulen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalıen_US
dc.identifier.volume7en_US
dc.identifier.issue1en_US
dc.identifier.startpage18en_US
dc.identifier.endpage24en_US
dc.institutionauthorAlpsoy, Şeref
dc.institutionauthorAkyüz, Aydın
dc.institutionauthorÖzkaramanlı Gür, Demet
dc.institutionauthorTopuz, Sahin
dc.institutionauthorGüler, Niyazi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.wosWOS:000514812200004en_US
dc.identifier.pmid32232199en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster